DERVAXIMYXO SG33
DERVAXIMYXO SG33
Not authorised
- Myxoma virus, strain SG 33, Live
- Water for injection
Product identification
Medicine name:
DERVAXIMYXO SG33
Active substance:
- Myxoma virus, strain SG 33, Live
- Water for injection
Target species:
-
Rabbit
-
Rabbit (for reproduction)
Route of administration:
-
Intradermal use
Product details
Active substance and strength:
-
Myxoma virus, strain SG 33, Live2.70/log10 cell culture infective dose 500.10millilitre(s)
-
Water for injection0.10/millilitre(s)0.10millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intradermal use
- Rabbit
-
All relevant tissues0day
-
- Rabbit (for reproduction)
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/2929459 4/2000
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
